BIOMERIEUX (EPA:BIM) | WebDisclosure

REGULATED PRESS RELEASE

published on 03/27/2024 at 18:01, 2 years 5 months ago

bioMérieux receives Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
bioMérieux receives 510(k) clearance and CLIA-waiver for BIOFIRE SPOTFIRE R/ST Panel, enhancing diagnostic capabilities for respiratory and sore throat infections globally

BioMérieux 510(k) Clearance BIOFIRE SPOTFIRE R/ST Panel CLIA-waiver Approval Diagnostic Testing
REGULATED PRESS RELEASE

published on 03/27/2024 at 18:01, 2 years 5 months ago

bioMérieux obtient l'agrément 510(k) et la dérogation CLIA pour le panel BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST)
bioMérieux obtient l'agrément 510(k) et la dérogation CLIA pour le panel BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST). Cette avancée renforce l'offre de tests rapides et innovants pour le diagnostic des infections respiratoires et pharyngées

BioMérieux Diagnostic Respiratoire Agrément 510(k) Dérogation CLIA Panel BIOFIRE® SPOTFIRE®
BRIEF

published on 03/25/2024 at 17:35, 2 years 5 months ago

Assemblée Générale Mixte de BIOMERIEUX Prévue pour le 23 Mai 2024

Actionnaires BioMérieux Assemblée Générale Documentation Modalités De Vote
BRIEF

published on 03/25/2024 at 17:35, 2 years 5 months ago

BIOMERIEUX Combined General Meeting Scheduled for May 23, 2024

Shareholders BioMérieux General Assembly Documentation Voting Conditions
REGULATED PRESS RELEASE

published on 03/25/2024 at 17:30, 2 years 5 months ago

AG 2024 - Avis de mise à disposition des documents préparatoires
Avis de convocation pour l'Assemblée générale mixte de bioMérieux le 23 mai 2024. Modalités de vote et informations disponibles sur le site de la société

Actionnaires BioMérieux Assemblée Générale Convocation Documents
ARTICLE

published on 03/14/2024 at 08:28, 2 years 6 months ago

bioMérieux envisage 2024 avec optimisme
Après une croissance de 6,6% de son chiffre d'affaires en 2023, bioMérieux anticipe une croissance de +6% à +8% en 2024

BioMérieux Perspectives 2024 Résultats Annuels 2023 Microbiologie BIOFIRE®
REGULATED PRESS RELEASE

published on 03/14/2024 at 07:01, 2 years 6 months ago

bioMérieux – Résultats annuels au 31 décembre 2023
REGULATED PRESS RELEASE

published on 03/14/2024 at 07:01, 2 years 6 months ago

bioMérieux – 2023 Financial Results
BRIEF

published on 03/04/2024 at 11:42, 2 years 6 months ago

BioMérieux annonce ses chiffres de droits de vote pour février 2024

Droits De Vote Capital Social BioMérieux Réglementation Février 2024
BRIEF

published on 03/04/2024 at 11:42, 2 years 6 months ago

BioMérieux announces its voting rights figures for February 2024

Share Capital Voting Rights BioMérieux Regulation February 2024

Published on 09/23/2026 at 22:00, 4 hours 14 minutes ago

Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 7 hours 49 minutes ago

Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 10 hours 32 minutes ago

Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 11 hours 43 minutes ago

First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 11 hours 44 minutes ago

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides

View all ACCESSWIRE

Published on 09/23/2026 at 23:00, 3 hours 14 minutes ago

Correction d’un communiqué du 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNONCE LE SUCCÈS DE SON AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION AINSI QU’UN REMBOURSEMENT PARTIEL D’OBLIGATIONS REMBOURSABLES EN ACTIONS
Published on 09/23/2026 at 23:00, 3 hours 14 minutes ago

Correction of a release from 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNOUNCES THE SUCCESS OF ITS CAPITAL INCREASE WITH PREFERENTIAL SUBSCRIPTION RIGHTS AND THE PARTIAL EARLY REDEMPTION OF BONDS REDEEMABLE IN SHARES
Published on 09/23/2026 at 19:51, 6 hours 23 minutes ago

LIGHTON: LightOn renouvelle son financement obligataire auprès des mêmes partenaires financiers pour un montant nominal maximum de 4 millions d’euros, et étend ainsi son horizon de trésorerie
Published on 09/23/2026 at 19:51, 6 hours 23 minutes ago

LIGHTON: LightOn renews its bond financing with the same financial partners for a maximum nominal amount of €4 million, and thus extends its cash flow horizon
Published on 09/23/2026 at 19:30, 6 hours 44 minutes ago

EUROPLASMA: Valdunes Industries et Saarstahl Ascoval s’associent pour développer une nouvelle génération de « roues vertes »

View all EQS

Published on 09/23/2026 at 19:46, 6 hours 28 minutes ago

SFPI GROUP: half year 2026 results
Published on 09/23/2026 at 19:46, 6 hours 28 minutes ago

SFPI GROUP: publication des résultats semestriels 2026
Published on 09/23/2026 at 19:14, 7 hours ago

Robust performance from Investments and continued execution of the strategy
Published on 09/23/2026 at 19:14, 7 hours ago

Performance robuste des Investissements, poursuite du déploiement de la stratégie
Published on 09/23/2026 at 18:00, 8 hours 14 minutes ago

CIS : H1 2026 results.

View all LES ECHOS COMFI WIRE

News